Dakota Wealth Management Has $765,000 Stake in Agilent Technologies, Inc. (NYSE:A)

Dakota Wealth Management lowered its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 10.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,696 shares of the medical research company’s stock after selling 673 shares during the quarter. Dakota Wealth Management’s holdings in Agilent Technologies were worth $765,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of A. McAdam LLC lifted its stake in Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock valued at $376,000 after buying an additional 77 shares in the last quarter. Brown Brothers Harriman & Co. lifted its position in Agilent Technologies by 13.5% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock valued at $96,000 after acquiring an additional 77 shares in the last quarter. Global Retirement Partners LLC boosted its stake in Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock worth $382,000 after purchasing an additional 79 shares during the period. Rovin Capital UT ADV increased its holdings in Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock worth $750,000 after purchasing an additional 81 shares in the last quarter. Finally, Marshall Financial Group LLC raised its stake in shares of Agilent Technologies by 1.0% in the 3rd quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock valued at $1,224,000 after purchasing an additional 82 shares during the period.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on A. JPMorgan Chase & Co. decreased their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Bank of America lowered their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Barclays reduced their target price on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a report on Wednesday, November 27th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $143.62.

Agilent Technologies Trading Down 0.8 %

Shares of Agilent Technologies stock opened at $151.24 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The business has a fifty day simple moving average of $137.95 and a two-hundred day simple moving average of $137.89. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a market capitalization of $43.19 billion, a price-to-earnings ratio of 34.22, a P/E/G ratio of 4.12 and a beta of 1.06.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Agilent Technologies’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.38 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st were issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.66%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date was Tuesday, December 31st. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.